Evidence map›Paper›PMID 41846261›Full record

ArticleCancer medicine2026

Epidemiology of Risk Stratification, Machine Learning Early Prediction Model, and Tumor Suppressive Mechanism of RHBDF2 in Esophageal Cancer in Gansu Province.

Duojie Zhu, Yinggang Che, Huijuan Cheng, Weiqi Wang, Yumin Li

Abstract read
In one paragraph

Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Duojie ZhuDepartment of Thoracic Surgery, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.ORCID https://orcid.org/0000-0002-0183-8257
Yinggang CheDepartment of Respiratory Medicine, Air Force Hospital of Western Theater Command, PLA, Chengdu, China.
Huijuan ChengThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Weiqi WangDepartment of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, China.
Yumin LiGansu Province Key Laboratory of Environmental Oncology, Lanzhou University, Lanzhou, China.ORCID https://orcid.org/0000-0002-9267-1412

Funding

Major Science and Technology Project of Gansu Province 20ZD7FA003Major Science and Technology Project of Gansu Province 22JR9KA00Major Science and Technology Project of Gansu Province 22ZD6FA050the Second Hospital of Lanzhou University Cuying Science and Technology Innovation Plan Project CY2021-BJ-A19the Shaanxi Province key research and development plan 2023-YBSF-230
6 · The paper itself

Abstract

backgroundEsophageal cancer imposes a considerable health burden in the high-risk areas of Northwest China, necessitating the development of effective biomarkers for its early detection to address this public health challenge.

methodsWe integrated multi-omics analysis, machine learning algorithms, and population epidemiology investigations in Gansu Province to screen and develop biomarkers for the early detection of esophageal cancer.

resultsEpidemiological findings revealed distinct geographical variations in esophageal cancer incidence, with Yugu County being the sole high-risk area (incidence rate: 54.2/100,000). Cases were predominantly in individuals aged > 40 years; males were the main affected population except in Yugu County. Protective factors for the disease included a healthy diet, regular exercise, and positive emotions, while smoking, alcohol consumption, and high-salt intake were identified as risk factors. A random forest machine learning model exhibited excellent predictive performance (AUC = 0.995) and identified key predictive factors for esophageal cancer. Proteomic analysis further revealed that RHBDF2 was downregulated and could serve as a potential biomarker for the disease.

conclusionsThis study provides robust epidemiological and molecular evidence for esophageal cancer prevention and early intervention strategies, and the identified potential biomarker RHBDF2 and high-performance predictive model offer valuable tools for the early detection of esophageal cancer in high-risk regions of Northwest China.

Indexed as

Biomarkers, TumorEsophageal NeoplasmsMachine LearningAdultAgedChinaEarly Detection of CancerHumansIncidenceMaleMiddle AgedPredictive Learning ModelsProteomicsRisk AssessmentRisk FactorsBiomarkers, Tumordietesophageal cancer epidemiologylifestyleprimary preventionRHBDF2

Identifiers

PMID41846261
PMCPMC13140592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.